These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27062488)

  • 21. Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan.
    Kumada H; Sato K; Takehara T; Nakamuta M; Ishigami M; Chayama K; Toyota J; Suzuki F; Nakayasu Y; Ochi M; Yamada I; Okanoue T
    Hepatol Res; 2015 Jul; 45(7):745-54. PubMed ID: 25196718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T; Takahashi S; Tatsukawa Y; Hiramatsu A; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Ishiyama K; Ide K; Tashiro H; Ohdan H; Chayama K
    Hepatol Res; 2014 Nov; 44(12):1259-64. PubMed ID: 24382214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.
    Xu Y; Qi W; Wang X; Zhao P; Zhang Y; Zhang Q; Qin S; Wang J
    Liver Int; 2014 Nov; 34(10):1522-31. PubMed ID: 25453135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan.
    Kumada H; Toyota J; Okanoue T; Chayama K; Tsubouchi H; Hayashi N
    J Hepatol; 2012 Jan; 56(1):78-84. PubMed ID: 21827730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.
    Villa E; Cammà C; Di Leo A; Karampatou A; Enea M; Gitto S; Bernabucci V; Losi L; De Maria N; Lei B; Ferrari A; Vukotic R; Vignoli P; Rendina M; Francavilla A
    J Viral Hepat; 2012 Sep; 19(9):640-9. PubMed ID: 22863268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.
    Furusyo N; Ogawa E; Nakamuta M; Kajiwara E; Nomura H; Dohmen K; Takahashi K; Satoh T; Azuma K; Kawano A; Tanabe Y; Kotoh K; Shimoda S; Hayashi J;
    J Hepatol; 2013 Aug; 59(2):205-12. PubMed ID: 23542346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients.
    Cure S; Bianic F; Gavart S; Curtis S; Lee S; Dusheiko G
    J Med Econ; 2014 Jan; 17(1):65-76. PubMed ID: 24160335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
    Laguno M; Cifuentes C; Murillas J; Veloso S; Larrousse M; Payeras A; Bonet L; Vidal F; Milinkovic A; Bassa A; Villalonga C; Pérez I; Tural C; Martínez-Rebollar M; Calvo M; Blanco JL; Martínez E; Sánchez-Tapias JM; Gatell JM; Mallolas J
    Hepatology; 2009 Jan; 49(1):22-31. PubMed ID: 19085908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
    Rustgi VK; Lee WM; Lawitz E; Gordon SC; Afdhal N; Poordad F; Bonkovsky HL; Bengtsson L; Chandorkar G; Harding M; McNair L; Aalyson M; Alam J; Kauffman R; Gharakhanian S; McHutchison JG;
    Hepatology; 2009 Dec; 50(6):1719-26. PubMed ID: 19852040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients.
    Pockros PJ; Jensen D; Tsai N; Taylor R; Ramji A; Cooper C; Dickson R; Tice A; Kulkarni R; Vierling JM; Lou Munson M; Chen YC; Najera I; Thommes J;
    Hepatology; 2013 Aug; 58(2):514-23. PubMed ID: 23359491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.
    Yamagiwa S; Ishikawa T; Waguri N; Sugitani S; Wakabayashi H; Ohkoshi S; Tsukishiro T; Takahashi T; Watanabe T; Terai S
    World J Hepatol; 2017 Feb; 9(5):252-262. PubMed ID: 28261382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan.
    Shiraishi M; Umebayashi I; Matsuda H; Sawamura K; Okada A; Karino M; Nogami Y
    Hepatol Res; 2015 Dec; 45(13):1267-75. PubMed ID: 25655428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.
    Ogawa E; Furusyo N; Kajiwara E; Nomura H; Dohmen K; Takahashi K; Nakamuta M; Satoh T; Azuma K; Kawano A; Tanabe Y; Kotoh K; Shimoda S; Hayashi J;
    Antiviral Res; 2014 Apr; 104():102-9. PubMed ID: 24462955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TT.
    Kawakami Y; Suzuki F; Karino Y; Toyota J; Kumada H; Chayama K
    Antivir Ther; 2014; 19(3):277-85. PubMed ID: 24192751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.
    Zeuzem S; Sulkowski MS; Lawitz EJ; Rustgi VK; Rodriguez-Torres M; Bacon BR; Grigorescu M; Tice AD; Lurie Y; Cianciara J; Muir AJ; Cronin PW; Pulkstenis E; Subramanian GM; McHutchison JG;
    Gastroenterology; 2010 Oct; 139(4):1257-66. PubMed ID: 20600013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
    Manns M; Marcellin P; Poordad F; de Araujo ES; Buti M; Horsmans Y; Janczewska E; Villamil F; Scott J; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):414-26. PubMed ID: 24907224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-life experience with first generation HCV protease inhibitor therapy in Germany: The prospective, non-interventional PAN cohort.
    Mauss S; Böker K; Buggisch P; Christensen S; Hofmann WP; Schott E; Pfeiffer-Vornkahl H; Alshuth U; Hüppe D
    Z Gastroenterol; 2015 Jul; 53(7):644-54. PubMed ID: 26167694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial.
    Benhamou Y; Moussalli J; Ratziu V; Lebray P; De Backer K; De Meyer S; Ghys A; Luo D; Picchio GR; Beumont M
    J Infect Dis; 2013 Sep; 208(6):1000-7. PubMed ID: 23801602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C.
    Fukuda K; Imai Y; Hiramatsu N; Irishio K; Igura T; Sawai Y; Kogita S; Makino Y; Mizumoto R; Matsumoto Y; Nakahara M; Zushi S; Kajiwara N; Oze T; Kawata S; Hayashi N; Takehara T
    Hepatol Res; 2014 Nov; 44(12):1165-71. PubMed ID: 24033816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.
    Coilly A; Roche B; Dumortier J; Leroy V; Botta-Fridlund D; Radenne S; Pageaux GP; Si-Ahmed SN; Guillaud O; Antonini TM; Haïm-Boukobza S; Roque-Afonso AM; Samuel D; Duclos-Vallée JC
    J Hepatol; 2014 Jan; 60(1):78-86. PubMed ID: 23994384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.